Inventor
HUANG RICHARD Y
US20 patents
⚠️ This page may combine multiple inventors who share the name “HUANG RICHARD Y”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
16 patentsUS10100129B2Oct 16, 2018
Antibodies against CD73 and uses thereof
BRISTOL MYERS SQUIBB CO24 citations93
US11213586B2Jan 4, 2022
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)
BRISTOL MYERS SQUIBB CO5 citations72
US10690674B2Jun 23, 2020
Anti-GITR antibodies for cancer diagnostics
BRISTOL MYERS SQUIBB CO5 citations71
US10167343B2Jan 1, 2019
Antibodies against CD73
BRISTOL MYERS SQUIBB CO3 citations71
US11524992B2Dec 13, 2022
Glypican-3-binding fibronectin based scaffold molecules
BRISTOL MYERS SQUIBB CO2 citations70
US10584160B2Mar 10, 2020
Glypican-3-binding fibronectin based scaffold molecules
BRISTOL MYERS SQUIBB CO3 citations70
US12077584B2Sep 3, 2024
Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)
BRISTOL MYERS SQUIBB CO1 citations69
US11274150B2Mar 15, 2022
Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies
BRISTOL MYERS SQUIBB CO2 citations69
US10556948B2Feb 11, 2020
IP-10 antibodies and their uses
BRISTOL MYERS SQUIBB CO2 citations69
US11242393B2Feb 8, 2022
Antibodies against MICA and/or MICB and uses thereof
BRISTOL MYERS SQUIBB CO3 citations67
US12110337B2Oct 8, 2024
Anti-CD27 antibodies and uses thereof
BRISTOL MYERS SQUIBB CO0 citations62
US11408889B2Aug 9, 2022
Anti-GITR antibodies for cancer diagnostics
BRISTOL MYERS SQUIBB CO1 citations61
US11352440B2Jun 7, 2022
Antibodies against CD73 and uses thereof
BRISTOL MYERS SQUIBB CO0 citations61
US12492238B2Dec 9, 2025
Glypican-3-binding fibronectin based scaffold molecules
BRISTOL MYERS SQUIBB CO0 citations59
US11981734B2May 14, 2024
Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
BRISTOL MYERS SQUIBB CO0 citations59
US11708405B2Jul 25, 2023
IP-10 antibodies and their uses
BRISTOL MYERS SQUIBB CO1 citations58
FIVE PRIME THERAPEUTICS INC
4 patentsUS12435136B2Oct 7, 2025
Antibodies binding to ILT4
FIVE PRIME THERAPEUTICS INC0 citations59
US11401328B2Aug 2, 2022
Antibodies binding to ILT4
FIVE PRIME THERAPEUTICS INC0 citations59
US12173069B2Dec 24, 2024
Antibodies binding to vista at acidic pH
FIVE PRIME THERAPEUTICS INC1 citations58
US12091462B2Sep 17, 2024
Antibodies binding to vista at acidic pH
FIVE PRIME THERAPEUTICS INC0 citations58